PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In addition, the PNPLA3 genotype has been elucidated as a modifier of NAFLD-associated metabolic systemic diseases such as carotid atherosclerosis [35] and chronic kidney disease [36].